| Lightcalls.com |
|
|
![]() |
greatest in quantity of us associat...greatest in quantity of us associate the denomination "bacteria" with harmful organisms and infectious disease, and at the same time without the presence of certain bacteria, none of us would survive infancy. Early 20th-century Nobel prize winner, Elie Metchnikoff, first deduc that more [i]or[/i] less bacteria actually play a lock opener role in maintaining optimum health. Research and experimentation for the nearest 90 years led to the conclusion that intestinal flora can be manipulated to benefit the armed force (us), and a new application of high-tech nutrition was born: probiotics. Probiotics is the system by which beneficial bacteria are introduced into the carcass by means of microbial regimen supplementation. While many strains of friendly bacteria are naturally occurring in the corpse including some members of the Bifidobacterium and Lactobacillus genera, several others are not. L bulgarium, for instance, isn't normally institute in the human intestine, and dissipates within sum of two units weeks after being introduced. Lactobacillus acidophilus is the main bacterial species of the small intestine, while Lactobacillus plantarum and bifidobacteria prevail in the large intestine, or colon These bacterial species and numerous others are clearly the "good guys" and their health-promoting good facts have not gone unnoticed by the medical and scientific community. L acidophilus is probably the species of beneficial bacteria principally familiar to us since it receives a good deal of attention for its ability to fight infection. It not solitary colonizes well in the intestine, but also in the urethra, colon and vagina. As most women know L acidophilus can effectively check recurring vaginal yeast infections and several studies support this claim. In vitro (test-tube) studies of L acidophilus strain LA1 and LB demonstrate they provide protection from several pathogens, including Staphylococcus aureus, Salmonella typhimurium, and Escherichia coli. Other in vitro studies indicate that L acidophilus, and its cousin, Bifidobacterium longum are capable of binding dietary and cooked food carcinogens. L acidophilus has also demonstrated the ability to boost the immune classification In one crossover, double-blind studious mood involving 15 adult patients with moderate allergic asthma, the immune response to yogurt containing L acidophilus was evaluated. While the researchers considered the improved clinical reply to be minimal, it was noted that the bacterial therapy drifted a decrease in the production of eosinophils (histamine-secreting cells) and an increase in interferon gamma plains Experiments with L. acidophilus reveal the capacity of this strain to improve lymphocyte production and their ability to endow interleukin-2 (IL-2), a protein which stimulates T-cell production and is used experimentally for a certain quantity of advanced cancers. Another strain of L acidophilus has been examined for its value in treating infective diarrhea caused by means of oral antibiotics. One study involved 63 children in a less degree than the age of 4 divided into three group The dispose treated with L. acidophilus showed significant clinical improvement compared to those who did not receive bacterial therapy. In addition, L acidophilus has also been shown to considerably decrease total cholesterol and LDL (the "bad" kind) cholesterol flushs in animal studies. Probiotics, or bacterial supplementation, solves the many difficulties of obtaining a sufficient amount of friendly bacteria via a normal diet. For one thing, in the greatest degree commercially prepared fermented foods (such as yogurt and hard cheese) may contain little or no live agricultures Supplementation is also attractive to lactose-intolerant individuals. Short of making in good condition yogurt or sauerkraut on a regular basis, it makes faculty of perception to supplement with beneficial bacteria. These "good bugs" -- set in foods containing live civilizations supplements, and beneficial-containing bacteria viands such as FOS -- are widely available. RELATED ARTICLE: proper your bacterial friends * Lactobacillus acidophilus: abridges cholesterol; fights pathogens; inhibits vaginal yeast and herpes virus; manages cystitis, eczema, and acne. * Lactobacillus bulgarium: destroys pathogens in large intestine when introduced; often used to treat rheumatoid arthritis. * Lactobacillus plantarum: remains in the large intestine for longer periods than other strains; places the `sour' in sauerkraut. * Bifidobacteria infantis: manufactures B vitamins; detoxifies the intestines. self-same mild and useful for children with feed allergies and infants having point to be solved [i]or[/i] settleds with breast milk. * Bifidobacterium: restrains pathogens; helpful in treating diarrhea, irritable bowel syndrome and constipation. COPYRIGHT 1998 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |